Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Hematologic Oncology 2018

About Conference


ConferenceSeries Ltd invites all the participants across the globe to attend the “14th International Conference on Leukemia and Hematologic Oncology” that will be held in Paris, France going to be held during June 20-21, 2018.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint provider ship of Peer Point Medical Education Institute and Conference Series, LLC. Peer Point Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Peer Opinion of Medical Education Institute designates to the live format for the instructive activity for AMA PRA Group 1 Credits™. Physicians should only claim credit commensurate with the extent of their input in the activity.

Hematologic Oncology 2018 will focus the latest and exciting modernisations in related areas of Leukemia and it will offer a unique opportunity for investigators from all over the world to meet, network, and perceive new scientific interactions. Leukemia is cancer of the blood cells. It starts in the bone marrow, the soft tissue inside most bones. Bone marrow is where blood cells are made. When you have leukemia, the bone marrow starts to make a lot of abnormal white blood cells, called leukemia cells. An estimated combined total of 156,420 people are expected to be diagnosed with leukemia in 2014. New cases of leukemia are expected to account for 9.4 percent of the estimated 1,665,540 new cancer cases diagnosed in 2014.

ConferenceSeries Ltd is a pioneer and leading scientific event organizer, publishing around 700 Open access journals and conducting over 1000 Scientific Meetings all over the globe annually with the support of more than 1000 scientific associations, 80,000 editorial board members, and 7.5 million followers to its credit.

Why to attend?

With members from around the world focused on learning about Leukemia and Hematologic Oncology; this is your best opportunity to reach the largest assemblage of participants from the Cancer community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Leukemia diagnosis, treatment and surgery involved are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event

Target Audience:

  • Hematologists
  • Cancer Specialists
  • Medical Oncologists
  • Immunologists
  • Pathologists
  • Research Scholars
  • Industrial professionals
  • Medical Students
  • Nurse Practitioners
  • Principle Investigators & Directors
  • Laboratory Researchers
  • Group Leaders
  • Cancer Diagnostic Professionals
  • Cancer & Oncology Societies Professionals
  • Bio-Medical Company professionals

Sessions | Tracks

ConferenceSeries Ltd invites all the participants from all over the world to attend 14th International Conference on Leukemia and Hematologic Oncology’’ during June 20-21, 2018 in Paris, France. This conference will be organized around the theme “Immense Opportunities to Network with Hematology & Oncology Researchers throughout the World"

Hematologic Oncology 2018 welcomes Hematologists, Oncologists, Immunologists, Pathologists, Research Scholars, Industrial Professionals and Student delegates from Biomedical and Healthcare sectors throughout the world to Success it.

Track-1

Leukemia

Leukemia is a harm of platelets. In leukemia, anomalous platelets are delivered in the bone marrow. Leukemia includes the creation of irregular white platelets the cells in charge of battling disease. The irregular cells in leukemia not work similarly as ordinary white platelets. The leukemia cells proceed to create and partition, at long last swarming out the typical platelets. The final product is that it winds up noticeably extreme for the body to battle contaminations, control drain, and carriage oxygen.

Acute myeloid leukemia (AML)

Chronic myeloid leukemia (CML)

Acute lymphocytic leukemia (ALL)

Chronic lymphocytic leukemia (CLL)

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

12th World Hematology Conference March 15-16, 2018 | London, UK; 25th Biennial European Association for Cancer Research Conference June 30-July3 2018 Amsterdam; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany; 28th Euro Cancer Science Conference and Cancer Therapy Conference August 09-10, 2018 | Madrid, Spain; 11th European Breast Cancer Conference Mar 21- 23, 2018 | Barcelona, Spain

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; British Society for Haematology, Europe; Egyptian Society of Hematology and Research;  ESMO: European Society for Medical Oncology, Europe; European Academy of Cancer Sciences, Europe; European Association for Cancer Research, Europe; European Cancer Organization: ECCO, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe; European School of Oncology, Europe; European Society for Pediatric Oncology – SIOPE, Europe; European Society of Skin Cancer Prevention, Europe: European Society of Surgical Oncology, Europe;  Federation of European Cancer Societies, Europe; International Society of Pediatric Oncology, Europe;  Organization of European Cancer Institute, Europe

Track-2

Hematology

Erythrocytes are otherwise called red platelets which convey oxygen to the body and gather carbon dioxide from the body by the utilization of hemoglobin and its life expectancy of 120 days. at the edge the leucocytes helps in ensuring the sound cells on the grounds that the W.B.C (leucocytes) go about as the shielding cells in shielding the resistant framework from the remote cells. Development of blood cell parts are called as Hematopoiesis and all the phone blood segments are gotten from hematopoiesis foundational microorganisms in a solid individual almost 1011– 1012 fresh recruits cells are created these assistance in unfaltering fringe course. On the off chance that there is an increments of R.B.C in the body these causes polycythemia these can be measured through hematocrit level.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

ESMO Sarcoma and GIST Symposium 2018 February 5-7, 2018 | Milan, Italy; Genitourinary Cancers Symposium February 8-10, 2018 | California, USA; 4th Annual on Gynecologic Oncology Conference July 18-19, 2018 | Atlanta, USA; ASH Meeting on Hematologic Malignancies September 7-8, 2018 | Chicago, IL; ASH Meeting on Lymphoma Biology August 2-5, 2018 | Washington, DC; ASH Summit on Emerging Immunotherapies for Hematologic Diseases July 12-13, 2018 | Washington, DC; Aga Khan University Joint Session - Surgical Oncology - Evidence & Practice February 2-3, 2018 | Karachi, Pakistan

Hematology Societies in USA

American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Head and Neck Society, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Canadian Hematology Society, USA; Childhood Brain Tumor Foundation, USA; Children's Tumor Foundation, USA; Colon Cancer Alliance, USA; Foundation for Women's Cancer, USA; International Society for Laboratory Hematology, USA; International Society of Hematology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; Lung Cancer Foundation of America, USA; Lymphoma Research Foundation, USA; Mexican Society of Hematology, USA; Michigan Society of Hematology and Oncology, USA

Track-3

Hematologic Oncology

Hematology-oncology solidifies such diseases as iron need whiteness, hemophilia, sickle cell sullying, the thalassemia’s, leukemias and lymphomas, and more infirmities of different organs. Treatment of hematology and oncology wires chemotherapy, radiotherapy, immunotherapy and pathway formed heads and so forth. Bone marrow transplantation or outskirts undifferentiated cell transplantation is in like way best in class utilized meds now days. The Oncology's authorities address noteworthy master in a broad assortment of improvements incorporates lymphomas, leukemia, diverse myeloma, chest, melanoma, lung, gastrointestinal, urologic, mind tumor, and every last other sort of risk.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

Hematology Global Summit 2018 September 20-21, 2018 | Bali, Indonesia; Surgical Oncology- Evidence & Practice February 2-3 2018 | Karachi, Pakistan; World Hematology Conference and Medical Oncology Conference May 28-30, 2018 | Osaka, Japan; ESMO Africa Cancer Conference February 14-16, 2018 | Cape Town, South Africa; Global Oncology Conference & Cancer Conference March 14-16, 2018 | Singapore; 4th World cancer Conference and Cancer Prevention Methods Conference April 19-21, 2018 | Valencia, Spain; Global Oncology Conference and Radiology Conference April 16-17, 2018 Dubai, UAE

Hematology Societies in Asia-Pacific

Asia Pacific Hematology Consortium, Asia-Pacific; Asian and Pacific Federation of Organizations for Cancer Research and Control, Asia-Pacific; Asian Cancer Foundation, Asia-Pacific; Asian Clinical Oncology Society: ACOS, Asia-Pacific; Asian Fund for Cancer Research, Asia-Pacific; Asian Hematology Association, Asia-Pacific; Asian Society of Gynecologic Oncology , Asia-Pacific; Australasian Lung Cancer Trials Group, Asia-Pacific ; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific ; Cancer Therapeutics Research Group, Asia-Pacific; Japanese Society of Hematology, Asia-Pacific ; Pan Arab Hematology Association, Asia-Pacific; The Thai Society of Hematology, Asia-Pacific

Track-4

Blood Disorders and Blood Oncology

Sickliness is the most widely recognized sort of blood issue we treat. Patients with iron deficiency have a lack of oxygen-rich red platelets or their red platelets don't work appropriately. A low level of hemoglobin, the iron-rich protein that conveys the oxygen in red platelets, flags the condition. Weakness can be interminable, or an impermanent condition caused by other medical problems, including malignancy treatment, hepatitis C, and HIV/AIDS. Iron deficiency every now and again stays undiscovered in light of the fact that it is a hidden state of other medical problems, including tumor, cardiovascular sickness, diabetes, HIV/AIDS, fiery entrail illness, perpetual kidney ailment, and rheumatoid joint pain. Hemophilia is an uncommon, regularly acquired blood issue in which the blood does not appropriately cluster and causes extreme dying, which can make harm organs, joints, and tissues. Patient may experience the ill effects of the site of damage or from inside dying.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

12th World Hematology Conference March 15-16, 2018 | London, UK; 25th Biennial European Association for Cancer Research Conference June 30-July3 2018 Amsterdam; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany; 28th Euro Cancer Science Conference and Cancer Therapy Conference August 09-10, 2018 | Madrid, Spain; 11th European Breast Cancer Conference Mar 21- 23, 2018 | Barcelona, Spain

Hematology Societies in South Africa

Africa Cancer Foundation, Africa; African Cancer Registry Network, Africa; African Journal of Cancer | Mediterranean Oncology Society, Africa; African Organization for Research and Training in Cancer, Africa; African Women’s Cancer Awareness Association, Africa; Afrox - Improving Cancer Care in Africa; CHOC Childhood Cancer Foundation South Africa; Haematology and Oncology Society of Africa; Morocco - World Health Organization Africa; Oncology for Africa ONLUS – Afron, Africa;  South African Clinical Haematology Society, Africa; South African Society of Haematology, Africa; World Health Organisation - Africa Region

Track-5

Leukemia Immunology

Cancer immunology is a branch of immunology that reviews cooperations between the safe framework and malignancycells. It is a developing field of research that expects to find imaginative tumor immunotherapies to treat and retard movement of the infection. The resistant reaction, including the acknowledgment of malignancy particular antigens, is specifically compelling in the field as information picked up drives the advancement of focused treatment and tumor marker-based symptomatic tests.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

ESMO Sarcoma and GIST Symposium 2018 February 5-7, 2018 | Milan, Italy; Genitourinary Cancers Symposium February 8-10, 2018 | California, USA; 4th Annual on Gynecologic Oncology Conference July 18-19, 2018 | Atlanta, USA; ASH Meeting on Hematologic Malignancies September 7-8, 2018 | Chicago, IL; ASH Meeting on Lymphoma Biology August 2-5, 2018 | Washington, DC; ASH Summit on Emerging Immunotherapies for Hematologic Diseases July 12-13, 2018 | Washington, DC; Aga Khan University Joint Session - Surgical Oncology - Evidence & Practice February 2-3, 2018 | Karachi, Pakistan

Hematology Societies in USA

American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Head and Neck Society, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Canadian Hematology Society, USA; Childhood Brain Tumor Foundation, USA; Children's Tumor Foundation, USA; Colon Cancer Alliance, USA; Foundation for Women's Cancer, USA; International Society for Laboratory Hematology, USA; International Society of Hematology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; Lung Cancer Foundation of America, USA; Lymphoma Research Foundation, USA; Mexican Society of Hematology, USA; Michigan Society of Hematology and Oncology, USA

Track-6

Leukemia Drugs

Chemotherapy is the standard treatment for some sorts of leukemia. Notwithstanding when a cure isn't conceivable, chemotherapy may enable you to live more and can rest easy. Chemotherapy for leukemia is normally a blend of medications. This is on the grounds that diverse medications assault leukemia cells in various ways. The mix likewise helps shield the leukemia cells from getting to be plainly impervious to any one medication. Alongside the chemotherapy drugs, different solutions might be given to help the chemotherapy drugs work better and avert disease or dying. These medications incorporate epoetin and hematopoietic stimulants.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

Hematology Global Summit 2018 September 20-21, 2018 | Bali, Indonesia; Surgical Oncology- Evidence & Practice February 2-3 2018 | Karachi, Pakistan; World Hematology Conference and Medical Oncology Conference May 28-30, 2018 | Osaka, Japan; ESMO Africa Cancer Conference February 14-16, 2018 | Cape Town, South Africa; Global Oncology Conference & Cancer Conference March 14-16, 2018 | Singapore; 4th World cancer Conference and Cancer Prevention Methods Conference April 19-21, 2018 | Valencia, Spain; Global Oncology Conference and Radiology Conference April 16-17, 2018 Dubai, UAE

Hematology Societies in Asia-Pacific

Asia Pacific Hematology Consortium, Asia-Pacific; Asian and Pacific Federation of Organizations for Cancer Research and Control, Asia-Pacific; Asian Cancer Foundation, Asia-Pacific; Asian Clinical Oncology Society: ACOS, Asia-Pacific; Asian Fund for Cancer Research, Asia-Pacific; Asian Hematology Association, Asia-Pacific; Asian Society of Gynecologic Oncology , Asia-Pacific; Australasian Lung Cancer Trials Group, Asia-Pacific ; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific ; Cancer Therapeutics Research Group, Asia-Pacific; Japanese Society of Hematology, Asia-Pacific ; Pan Arab Hematology Association, Asia-Pacific; The Thai Society of Hematology, Asia-Pacific

Track-7

Anemia & Bleeding Disorders

Pallor is a lessening in the aggregate sum of red platelets or hemoglobin in the blood or a brought capacity of the blood down to convey oxygen. Having weakness may influence you to feel drained and frail. There are many types of sickliness, each with its own motivation. Sickliness can be transitory or long haul, and it can go from mellow to extreme. The three principle sorts of paleness are because of blood misfortune, diminished red platelet creation, and expanded red platelet breakdown.

Draining disarranges are a gathering of conditions that outcome when the blood can't cluster appropriately. In ordinary coagulating, platelets, a sort of platelet, stick together and frame a fitting at the site of a harmed vein. Proteins in the blood called coagulating factors at that point connect to shape a fibrin coagulation, basically a gel plug, which holds the platelets set up and enables recuperating to happen at the site of the damage while keeping blood from getting away from the vein. While an excess of thickening can prompt conditions, for example, heart assaults and strokes, the powerlessness to shape clusters can be exceptionally risky also, as it can bring about inordinate dying.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

12th World Hematology Conference March 15-16, 2018 | London, UK; 25th Biennial European Association for Cancer Research Conference June 30-July3 2018 Amsterdam; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany; 28th Euro Cancer Science Conference and Cancer Therapy Conference August 09-10, 2018 | Madrid, Spain; 11th European Breast Cancer Conference Mar 21- 23, 2018 | Barcelona, Spain

Hematology Societies in South Africa

Africa Cancer Foundation, Africa; African Cancer Registry Network, Africa; African Journal of Cancer | Mediterranean Oncology Society, Africa; African Organization for Research and Training in Cancer, Africa; African Women’s Cancer Awareness Association, Africa; Afrox - Improving Cancer Care in Africa; CHOC Childhood Cancer Foundation South Africa; Haematology and Oncology Society of Africa; Morocco - World Health Organization Africa; Oncology for Africa ONLUS – Afron, Africa;  South African Clinical Haematology Society, Africa; South African Society of Haematology, Africa; World Health Organisation - Africa Region

Track-8

Haematologic Malignancies

Hematologic malignancies are types of tumor that starts in the cells of blood-shaping tissue, for example, the bone marrow, or in the cells of the resistant framework. Cases of hematologic growth are intense and incessant leukemia, lymphomas, different myeloma and myelodysplastic disorders. Myeloproliferative neoplasms, or MPNs, are hematologic tumors that emerge from threatening hematopoietic myeloid forebear cells in the bone marrow, for example, the forerunner cells of red cells, platelets and granulocytes. Incorporated into the MPN ailment range are fundamental thrombocythemia, polycythemia Vera and myelofibrosis. This logical session will concentrate on a wide range of normal or uncommon blood growths, for example, intense promyelocytic leukemia and constant myelomonocytic leukemia shaggy cell leukemia, huge granular lymphocytic leukemia, immune system microorganism intense lymphoblastic leukemia, Non-Hodgkin lymphoma and Hodgkin lymphoma Multiple myeloma, Childhood Leukemia and Myelodysplastic-Myeloproliferative infections.        

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

ESMO Sarcoma and GIST Symposium 2018 February 5-7, 2018 | Milan, Italy; Genitourinary Cancers Symposium February 8-10, 2018 | California, USA; 4th Annual on Gynecologic Oncology Conference July 18-19, 2018 | Atlanta, USA; ASH Meeting on Hematologic Malignancies September 7-8, 2018 | Chicago, IL; ASH Meeting on Lymphoma Biology August 2-5, 2018 | Washington, DC; ASH Summit on Emerging Immunotherapies for Hematologic Diseases July 12-13, 2018 | Washington, DC; Aga Khan University Joint Session - Surgical Oncology - Evidence & Practice February 2-3, 2018 | Karachi, Pakistan

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; British Society for Haematology, Europe; Egyptian Society of Hematology and Research;  ESMO: European Society for Medical Oncology, Europe; European Academy of Cancer Sciences, Europe; European Association for Cancer Research, Europe; European Cancer Organization: ECCO, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe; European School of Oncology, Europe; European Society for Pediatric Oncology – SIOPE, Europe; European Society of Skin Cancer Prevention, Europe: European Society of Surgical Oncology, Europe;  Federation of European Cancer Societies, Europe; International Society of Pediatric Oncology, Europe;  Organization of European Cancer Institute, Europe

Track-9

Lymphoma

Lymphoma is a sort of blood disease that influences the lymphatic framework, which expels overabundance liquids from your body and creates insusceptible cells. Lymphocytes are a sort of white platelet that battle disease. Unusual lymphocytes move toward becoming lymphoma cells, which duplicate and gather in your lymph hubs and different tissues. After some time, these malignant cells impede your resistant framework.

In the event that you have lymphoma it implies you make an excessive number of lymphocytes, a kind of white platelet. Your lymphocytes additionally live longer than they should. This over-burden bargains your safe framework. Lymphoma can create in many parts of your body, including your lymph hubs, bone marrow, blood, spleen and different organs. Sorts of lymphoma are Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

Hematology Global Summit 2018 September 20-21, 2018 | Bali, Indonesia; Surgical Oncology- Evidence & Practice February 2-3 2018 | Karachi, Pakistan; World Hematology Conference and Medical Oncology Conference May 28-30, 2018 | Osaka, Japan; ESMO Africa Cancer Conference February 14-16, 2018 | Cape Town, South Africa; Global Oncology Conference & Cancer Conference March 14-16, 2018 | Singapore; 4th World cancer Conference and Cancer Prevention Methods Conference April 19-21, 2018 | Valencia, Spain; Global Oncology Conference and Radiology Conference April 16-17, 2018 Dubai, UAE

Hematology Societies in USA

American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Head and Neck Society, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Canadian Hematology Society, USA; Childhood Brain Tumor Foundation, USA; Children's Tumor Foundation, USA; Colon Cancer Alliance, USA; Foundation for Women's Cancer, USA; International Society for Laboratory Hematology, USA; International Society of Hematology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; Lung Cancer Foundation of America, USA; Lymphoma Research Foundation, USA; Mexican Society of Hematology, USA; Michigan Society of Hematology and Oncology, USA

Track-10

Myeloma

Myeloma is a growth of the plasma cells. Plasma cells are white platelets that create malady and contamination battling antibodies in your body. Myeloma cells keep the typical creation of antibodies, leaving your body's insusceptible framework debilitated and helpless to contamination.

Threatening melanoma is prevalently an infection of the skin, yet may in uncommon occasions happen at different destinations, including the mucous films, and also in the eye. Melanoma emerges from melanocytes, which are cells situated in the upper layer of the skin that are in charge of creating shade. Most melanomas are dim in shading since they contain color; be that as it may, a few melanomas don't contain color and are hard to analyze.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

12th World Hematology Conference March 15-16, 2018 | London, UK; 25th Biennial European Association for Cancer Research Conference June 30-July3 2018 Amsterdam; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany; 28th Euro Cancer Science Conference and Cancer Therapy Conference August 09-10, 2018 | Madrid, Spain; 11th European Breast Cancer Conference Mar 21- 23, 2018 | Barcelona, Spain

Hematology Societies in Asia-Pacific

Asia Pacific Hematology Consortium, Asia-Pacific; Asian and Pacific Federation of Organizations for Cancer Research and Control, Asia-Pacific; Asian Cancer Foundation, Asia-Pacific; Asian Clinical Oncology Society: ACOS, Asia-Pacific; Asian Fund for Cancer Research, Asia-Pacific; Asian Hematology Association, Asia-Pacific; Asian Society of Gynecologic Oncology , Asia-Pacific; Australasian Lung Cancer Trials Group, Asia-Pacific ; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific ; Cancer Therapeutics Research Group, Asia-Pacific; Japanese Society of Hematology, Asia-Pacific ; Pan Arab Hematology Association, Asia-Pacific; The Thai Society of Hematology, Asia-Pacific

Track-11

Hematologic Malignancies: Prognosis

The estimation of how the infection will go for a patient is called anticipation. There are many components influence visualization that include: the sort of disease and where it is in the body, the phase of the growth, the malignancy's review. Review gives pieces of information about how rapidly the malignancy is probably going to develop and spread certain attributes of the disease cells, the age and how complete body was before growth and how effective is the treatment.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

ESMO Sarcoma and GIST Symposium 2018 February 5-7, 2018 | Milan, Italy; Genitourinary Cancers Symposium February 8-10, 2018 | California, USA; 4th Annual on Gynecologic Oncology Conference July 18-19, 2018 | Atlanta, USA; ASH Meeting on Hematologic Malignancies September 7-8, 2018 | Chicago, IL; ASH Meeting on Lymphoma Biology August 2-5, 2018 | Washington, DC; ASH Summit on Emerging Immunotherapies for Hematologic Diseases July 12-13, 2018 | Washington, DC; Aga Khan University Joint Session - Surgical Oncology - Evidence & Practice February 2-3, 2018 | Karachi, Pakistan

Hematology Societies in South Africa

Africa Cancer Foundation, Africa; African Cancer Registry Network, Africa; African Journal of Cancer | Mediterranean Oncology Society, Africa; African Organization for Research and Training in Cancer, Africa; African Women’s Cancer Awareness Association, Africa; Afrox - Improving Cancer Care in Africa; CHOC Childhood Cancer Foundation South Africa; Haematology and Oncology Society of Africa; Morocco - World Health Organization Africa; Oncology for Africa ONLUS – Afron, Africa;  South African Clinical Haematology Society, Africa; South African Society of Haematology, Africa; World Health Organisation - Africa Region

Track-12

Immunohematology

Immunohematology is referred to as blood managing an account also, is a branch of Hematology which contemplates antigen-counter acting agent responses and comparative wonders as they identify with the pathogenesis and clinical indications of blood issue. Individuals working in this field are noted to as an immuno-hematologist. Their standard obligations incorporate cross-coordinating, blood writing and immune response recognizable proof. This region is managing planning blood, blood parts and so on for transfusion and variety of more good segments for blood transfusion. Individuals may be vaccinated to RBCs due to earlier contact to RBCs of different people, as often as possible through pregnancy or transfusion.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

Hematology Global Summit 2018 September 20-21, 2018 | Bali, Indonesia; Surgical Oncology- Evidence & Practice February 2-3 2018 | Karachi, Pakistan; World Hematology Conference and Medical Oncology Conference May 28-30, 2018 | Osaka, Japan; ESMO Africa Cancer Conference February 14-16, 2018 | Cape Town, South Africa; Global Oncology Conference & Cancer Conference March 14-16, 2018 | Singapore; 4th World cancer Conference and Cancer Prevention Methods Conference April 19-21, 2018 | Valencia, Spain; Global Oncology Conference and Radiology Conference April 16-17, 2018 Dubai, UAE

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; British Society for Haematology, Europe; Egyptian Society of Hematology and Research;  ESMO: European Society for Medical Oncology, Europe; European Academy of Cancer Sciences, Europe; European Association for Cancer Research, Europe; European Cancer Organization: ECCO, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe; European School of Oncology, Europe; European Society for Pediatric Oncology – SIOPE, Europe; European Society of Skin Cancer Prevention, Europe: European Society of Surgical Oncology, Europe;  Federation of European Cancer Societies, Europe; International Society of Pediatric Oncology, Europe;  Organization of European Cancer Institute, Europe

Track-13

Biomarkers in Hematology

Protein Biomarkers can be utilized as biomarkers for early location of tumors particularly utilized for the ID of bosom growth. Symptomatic Patients with suspected pancreatic malignancy will experience an underlying CT sweep to decide whether a presume mass is confined and evacuated by surgery 63% of patients will be determined to have non-resectable stage III and IV ailment and a biopsy will be attempted to affirm pancreatic disease by H&E neurotic examination. The nearness of harmful cells through pathology is exceptionally testing because of high quantities of non-malignant stromal penetrating cells and organization of chemotherapy or enrolment into a clinical trial will just start on complete finding of pancreatic disease. These will see particularly recolors neoplastic pancreatic cells would empower the pathologist to certainly analyze pancreatic tumor and hence offer suitable disease treatment to the patients. The Novel Biomarker BI-010 has been distinguished as a very delicate (98%) and particular (95%) IHC marker for pancreatic disease and CRT is looking for an accomplice to build up an IHC based test to recognize BI-010 in fine needle suction biopsies from biopsy tests.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

12th World Hematology Conference March 15-16, 2018 | London, UK; 25th Biennial European Association for Cancer Research Conference June 30-July3 2018 Amsterdam; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany; 28th Euro Cancer Science Conference and Cancer Therapy Conference August 09-10, 2018 | Madrid, Spain; 11th European Breast Cancer Conference Mar 21- 23, 2018 | Barcelona, Spain

Hematology Societies in USA

American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Head and Neck Society, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Canadian Hematology Society, USA; Childhood Brain Tumor Foundation, USA; Children's Tumor Foundation, USA; Colon Cancer Alliance, USA; Foundation for Women's Cancer, USA; International Society for Laboratory Hematology, USA; International Society of Hematology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; Lung Cancer Foundation of America, USA; Lymphoma Research Foundation, USA; Mexican Society of Hematology, USA; Michigan Society of Hematology and Oncology, USA

Track-14

Hematopathology

Hematopathology or hemopathology is the subdivision of pathology which examines clutters of hematopoietic cells. Hematopathology is an affirmed subspecialty, rehearsed by those doctors who have completed general pathologyresidency. The Hematopathology branch conveys logical administrations and particular testing for patients with a wide range of hematologic issue. The Hematopathology gives symptomatic evaluation of blood, bone marrow, lymph hubs, spleen, and hematolymphoid sores in different locales.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

ESMO Sarcoma and GIST Symposium 2018 February 5-7, 2018 | Milan, Italy; Genitourinary Cancers Symposium February 8-10, 2018 | California, USA; 4th Annual on Gynecologic Oncology Conference July 18-19, 2018 | Atlanta, USA; ASH Meeting on Hematologic Malignancies September 7-8, 2018 | Chicago, IL; ASH Meeting on Lymphoma Biology August 2-5, 2018 | Washington, DC; ASH Summit on Emerging Immunotherapies for Hematologic Diseases July 12-13, 2018 | Washington, DC; Aga Khan University Joint Session - Surgical Oncology - Evidence & Practice February 2-3, 2018 | Karachi, Pakistan

Hematology Societies in Asia-Pacific

Asia Pacific Hematology Consortium, Asia-Pacific; Asian and Pacific Federation of Organizations for Cancer Research and Control, Asia-Pacific; Asian Cancer Foundation, Asia-Pacific; Asian Clinical Oncology Society: ACOS, Asia-Pacific; Asian Fund for Cancer Research, Asia-Pacific; Asian Hematology Association, Asia-Pacific; Asian Society of Gynecologic Oncology , Asia-Pacific; Australasian Lung Cancer Trials Group, Asia-Pacific ; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific ; Cancer Therapeutics Research Group, Asia-Pacific; Japanese Society of Hematology, Asia-Pacific ; Pan Arab Hematology Association, Asia-Pacific; The Thai Society of Hematology, Asia-Pacific

Track-15

Bone Marrow Transplantation and Surgery

Bone Marrow Transplantation: A bone marrow transplant, otherwise called a haemopoietic immature microorganism transplant, replaces harmed bone marrow with sound bone marrow undeveloped cells. Bone marrow is an elastic tissue found in the empty focuses of a few bones. It contains master undifferentiated organisms, which create the body's platelets.

A biopsy is an example of tissue taken from the body with a specific end goal to look at it all the more intently. A specialist ought to prescribe a biopsy when an underlying test recommends that a territory of tissue in the body isn't typical. Specialists may call that zone of unusual tissue an injury, a tumor, or a mass. Subjects of talk in the logical sessions are Bone Marrow Surgery, Stem Cell Surgery, Hematopoietic Cell Transplantations.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

Hematology Global Summit 2018 September 20-21, 2018 | Bali, Indonesia; Surgical Oncology- Evidence & Practice February 2-3 2018 | Karachi, Pakistan; World Hematology Conference and Medical Oncology Conference May 28-30, 2018 | Osaka, Japan; ESMO Africa Cancer Conference February 14-16, 2018 | Cape Town, South Africa; Global Oncology Conference & Cancer Conference March 14-16, 2018 | Singapore; 4th World cancer Conference and Cancer Prevention Methods Conference April 19-21, 2018 | Valencia, Spain; Global Oncology Conference and Radiology Conference April 16-17, 2018 Dubai, UAE

Hematology Societies in South Africa

Africa Cancer Foundation, Africa; African Cancer Registry Network, Africa; African Journal of Cancer | Mediterranean Oncology Society, Africa; African Organization for Research and Training in Cancer, Africa; African Women’s Cancer Awareness Association, Africa; Afrox - Improving Cancer Care in Africa; CHOC Childhood Cancer Foundation South Africa; Haematology and Oncology Society of Africa; Morocco - World Health Organization Africa; Oncology for Africa ONLUS – Afron, Africa;  South African Clinical Haematology Society, Africa; South African Society of Haematology, Africa; World Health Organisation - Africa Region

Track-16

Pediatric Hematology

Pediatric Hematology is a branch of Hematology which deals with the treatment and care of child or teen having Blood Disorder. A paediatric hematologist has the qualifications and experience to evaluate and treat child or teen with Hematologic Disorders. The caring nature to deal with children or teens with blood diseases and blood cancers is learned from progressive training and experience in practice. Pediatric hematologists treat children and teens from birth through young adulthood. Children and teens with blood disorders need special attention than adults. Their bodies are growing and have distinctive medical needs.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

12th World Hematology Conference March 15-16, 2018 | London, UK; 25th Biennial European Association for Cancer Research Conference June 30-July3 2018 Amsterdam; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany; 28th Euro Cancer Science Conference and Cancer Therapy Conference August 09-10, 2018 | Madrid, Spain; 11th European Breast Cancer Conference Mar 21- 23, 2018 | Barcelona, Spain

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; British Society for Haematology, Europe; Egyptian Society of Hematology and Research;  ESMO: European Society for Medical Oncology, Europe; European Academy of Cancer Sciences, Europe; European Association for Cancer Research, Europe; European Cancer Organization: ECCO, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe; European School of Oncology, Europe; European Society for Pediatric Oncology – SIOPE, Europe; European Society of Skin Cancer Prevention, Europe: European Society of Surgical Oncology, Europe;  Federation of European Cancer Societies, Europe; International Society of Pediatric Oncology, Europe;  Organization of European Cancer Institute, Europe

Track-17

Advance in Bone Marrow Transplantation

An expanding number of sicknesses might be dealt with effectively by allogeneic bone marrow transplantation (BMT). At first utilized for the treatment of immunodeficiency where a cell arrangement or item is supplanted, it has now turned out to be normal treatment for some types of leukemia where the transplant gives the safeguard after deadly marrow removal. As of late, maladies, for example, thalassemia and other acquired metabolic infections have additionally been dealt with by BMT. Some time ago the issues of BMT were mostly worried about unite versus have malady (GVHD) in HLA-coordinated transplants with HLA-jumbled ones not being conceivable as GVHD was typically deadly. Since the improvement of systems for T cell evacuation the frequency of GVHD has incredibly reduced. White blood cell evacuation has likewise permitted HLA haploidentical crisscrossed unions to be performed effectively for immunodeficiency, yet there is as yet a high join dismissal rate in leukemia.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

ESMO Sarcoma and GIST Symposium 2018 February 5-7, 2018 | Milan, Italy; Genitourinary Cancers Symposium February 8-10, 2018 | California, USA; 4th Annual on Gynecologic Oncology Conference July 18-19, 2018 | Atlanta, USA; ASH Meeting on Hematologic Malignancies September 7-8, 2018 | Chicago, IL; ASH Meeting on Lymphoma Biology August 2-5, 2018 | Washington, DC; ASH Summit on Emerging Immunotherapies for Hematologic Diseases July 12-13, 2018 | Washington, DC; Aga Khan University Joint Session - Surgical Oncology - Evidence & Practice February 2-3, 2018 | Karachi, Pakistan

Hematology Societies in USA

American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Head and Neck Society, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Canadian Hematology Society, USA; Childhood Brain Tumor Foundation, USA; Children's Tumor Foundation, USA; Colon Cancer Alliance, USA; Foundation for Women's Cancer, USA; International Society for Laboratory Hematology, USA; International Society of Hematology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; Lung Cancer Foundation of America, USA; Lymphoma Research Foundation, USA; Mexican Society of Hematology, USA; Michigan Society of Hematology and Oncology, USA

Track-18

Hematology Nursing

Hematology medical caretakers are particularly gifted to give nursing consideration to patients with blood illnesses or clutters. They may likewise help with blood transfusions, blood tests, research, and chemotherapy. On the off chance that you go into hematology, hope to have more commitment than different medical attendants, prescriptive master, and the capacity to arrange demonstrative lab work. A portion of the extra normally referred to blood ailments and disarranges, for example, leukemia, lymphoma, sickle cell iron deficiency and hemophilia are experience by hematology medical caretakers. Hematology medical attendants start an arrangement of care to oversee side effects that outcome from such blood issues

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

12th World Hematology Conference March 15-16, 2018 | London, UK; 25th Biennial European Association for Cancer Research Conference June 30-July3 2018 Amsterdam; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany; 28th Euro Cancer Science Conference and Cancer Therapy Conference August 09-10, 2018 | Madrid, Spain; 11th European Breast Cancer Conference Mar 21- 23, 2018 | Barcelona, Spain

Hematology Societies in South Africa

Africa Cancer Foundation, Africa; African Cancer Registry Network, Africa; African Journal of Cancer | Mediterranean Oncology Society, Africa; African Organization for Research and Training in Cancer, Africa; African Women’s Cancer Awareness Association, Africa; Afrox - Improving Cancer Care in Africa; CHOC Childhood Cancer Foundation South Africa; Haematology and Oncology Society of Africa; Morocco - World Health Organization Africa; Oncology for Africa ONLUS – Afron, Africa;  South African Clinical Haematology Society, Africa; South African Society of Haematology, Africa; World Health Organisation - Africa Region

Track-19

Stem Cell Research

Stem cells have the remarkable potential to turn into many different cell types within the body throughout formative years and growth. Additionally, in several tissues they function as a sort of internal repair system, dividing basically without any limit to replenish other cells as long as the person or animal continues to be alive. Once a stem cell splits, each newly developed cell has the probable to stay as a stem cell or become another diversity of cell with a more particular function, like a muscle cell, a red blood corpuscle, or a nerve cell. Stem-cell therapy is the use of stem cells to treat or cure a disease or condition. Bone marrow transplant is the most commonly used stem-cell therapy; however some therapies derived from umbilical cord blood also are in use.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

Hematology Global Summit 2018 September 20-21, 2018 | Bali, Indonesia; Surgical Oncology- Evidence & Practice February 2-3 2018 | Karachi, Pakistan; World Hematology Conference and Medical Oncology Conference May 28-30, 2018 | Osaka, Japan; ESMO Africa Cancer Conference February 14-16, 2018 | Cape Town, South Africa; Global Oncology Conference & Cancer Conference March 14-16, 2018 | Singapore; 4th World cancer Conference and Cancer Prevention Methods Conference April 19-21, 2018 | Valencia, Spain; Global Oncology Conference and Radiology Conference April 16-17, 2018 Dubai, UAE

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; British Society for Haematology, Europe; Egyptian Society of Hematology and Research;  ESMO: European Society for Medical Oncology, Europe; European Academy of Cancer Sciences, Europe; European Association for Cancer Research, Europe; European Cancer Organization: ECCO, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe; European School of Oncology, Europe; European Society for Pediatric Oncology – SIOPE, Europe; European Society of Skin Cancer Prevention, Europe: European Society of Surgical Oncology, Europe;  Federation of European Cancer Societies, Europe; International Society of Pediatric Oncology, Europe;  Organization of European Cancer Institute, Europe

Track-20

Hematology Market

The worldwide Hematology diagnostics and medications advertise is probably going to extend from about $86.5 billion out of 2015 to $124.3 billion out of 2020 at a five-year compound yearly development rate (CAGR) of 7.5%. A Blood issue, the central fragment is foreseen to reach about $57.3 billion and $80 billion out of 2015 and 2020, individually, speaking to five-year CAGR of 6.9%. Hematological oncology is the quickest developing fragment, should bring nearly $24 billion up in 2015 to $38.2 billion of every 2020 at a five-year CAGR of 9.7%. Reagents and diagnostics as a portion should reach $6.1 billion of every 2020 at a five-year CAGR of 3.2%.

The Americas controlled the biggest offer of 41.75% of the overall Hematology showcase at an anticipated $1,810.4 million of every 2013, expected to reach $2,479.05 million by 2018, at a CAGR of 6% from 2013 to 2018. Europe holds the second biggest Hematology piece of the overall industry. Germany exact the biggest offer right around 20% of the European market at a foreseen $272.8 million out of 2013, and is assessed to get a handle on $349.7 million by 2018, at a CAGR of 5.4% from 2013 to 2018. The Asia and Middle East Hematology showcase is developing in twofold digits and will stay to develop in the forthcoming years. China controlled the significant offer of right around 53% of the Asian Hematology advertise at an anticipated $216.0 million out of 2013, assessed and is to get a handle on $429.1 million by 2018, at a CAGR of 15.4% from 2013 to 2018.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

ESMO Sarcoma and GIST Symposium 2018 February 5-7, 2018 | Milan, Italy; Genitourinary Cancers Symposium February 8-10, 2018 | California, USA; 4th Annual on Gynecologic Oncology Conference July 18-19, 2018 | Atlanta, USA; ASH Meeting on Hematologic Malignancies September 7-8, 2018 | Chicago, IL; ASH Meeting on Lymphoma Biology August 2-5, 2018 | Washington, DC; ASH Summit on Emerging Immunotherapies for Hematologic Diseases July 12-13, 2018 | Washington, DC; Aga Khan University Joint Session - Surgical Oncology - Evidence & Practice February 2-3, 2018 | Karachi, Pakistan

Hematology Societies in USA

American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Head and Neck Society, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Canadian Hematology Society, USA; Childhood Brain Tumor Foundation, USA; Children's Tumor Foundation, USA; Colon Cancer Alliance, USA; Foundation for Women's Cancer, USA; International Society for Laboratory Hematology, USA; International Society of Hematology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; Lung Cancer Foundation of America, USA; Lymphoma Research Foundation, USA; Mexican Society of Hematology, USA; Michigan Society of Hematology and Oncology, USA

Track-21

Case reports and Epidemiology

A case report is typically viewed as a sort of narrative evidence. Given their inborn strategy impediments, including nonappearance of factual inspecting, case reports are put at the foot of the pecking order of clinical verification, close to case arrangement. Be that as it may, Hematology case reports do have really supportive parts in restorative research and proof based medications. In particular, they require encouraged acknowledgment of late maladies and unfriendly impacts of medications. For example, acknowledgment of the connection between organization of teratogen to moms and mutations in their infants was recommended by the report of a particular case. Case reports have an undertaking in pharmacovigilance.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

12th World Hematology Conference March 15-16, 2018 | London, UK; 25th Biennial European Association for Cancer Research Conference June 30-July3 2018 Amsterdam; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany; 28th Euro Cancer Science Conference and Cancer Therapy Conference August 09-10, 2018 | Madrid, Spain; 11th European Breast Cancer Conference Mar 21- 23, 2018 | Barcelona, Spain

Hematology Societies in Asia-Pacific

Asia Pacific Hematology Consortium, Asia-Pacific; Asian and Pacific Federation of Organizations for Cancer Research and Control, Asia-Pacific; Asian Cancer Foundation, Asia-Pacific; Asian Clinical Oncology Society: ACOS, Asia-Pacific; Asian Fund for Cancer Research, Asia-Pacific; Asian Hematology Association, Asia-Pacific; Asian Society of Gynecologic Oncology , Asia-Pacific; Australasian Lung Cancer Trials Group, Asia-Pacific ; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific ; Cancer Therapeutics Research Group, Asia-Pacific; Japanese Society of Hematology, Asia-Pacific ; Pan Arab Hematology Association, Asia-Pacific; The Thai Society of Hematology, Asia-Pacific

Track-22

Platelets

Platelets, additionally called thrombocytes are a part of blood whose capacity is to quit seeping by clustering and thickening vein wounds. Platelets have no cell core: they are pieces of cytoplasm that are gotten from the megakaryocytes of the bone marrow, and after that enter the flow. These unactivated platelets are biconvex discoid structures, 2-3 µm in most prominent distance across. Platelets are discovered just in well evolved creatures, while in different creatures thrombocytes circle as in place mononuclear cells. The primary capacity of platelets is to add to hemostasis: the way toward halting seeping at the site of interfered with endothelium. They assemble at the site and unless the interference is physically too substantial, they plug the gap.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

Hematology Global Summit 2018 September 20-21, 2018 | Bali, Indonesia; Surgical Oncology- Evidence & Practice February 2-3 2018 | Karachi, Pakistan; World Hematology Conference and Medical Oncology Conference May 28-30, 2018 | Osaka, Japan; ESMO Africa Cancer Conference February 14-16, 2018 | Cape Town, South Africa; Global Oncology Conference & Cancer Conference March 14-16, 2018 | Singapore; 4th World cancer Conference and Cancer Prevention Methods Conference April 19-21, 2018 | Valencia, Spain; Global Oncology Conference and Radiology Conference April 16-17, 2018 Dubai, UAE

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; British Society for Haematology, Europe; Egyptian Society of Hematology and Research;  ESMO: European Society for Medical Oncology, Europe; European Academy of Cancer Sciences, Europe; European Association for Cancer Research, Europe; European Cancer Organization: ECCO, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe; European School of Oncology, Europe; European Society for Pediatric Oncology – SIOPE, Europe; European Society of Skin Cancer Prevention, Europe: European Society of Surgical Oncology, Europe;  Federation of European Cancer Societies, Europe; International Society of Pediatric Oncology, Europe;  Organization of European Cancer Institute, Europe

Track-23

Myelodysplastic Syndromes

Myelodysplastic disorders are a gathering of diseases in which juvenile platelets in the bone marrow don't develop and in this way don't end up noticeably solid platelets. At an early stage there are ordinarily no indications. Later side effects may incorporate feeling tired, shortness of breath, simple dying, or successive contaminations. A few sorts may form into intense myeloid leukemia.

Hazard factors incorporate past chemotherapy or radiation treatment, presentation to specific chemicals, for example, tobacco smoke, pesticides, and benzene, and introduction to substantial metals, for example, mercury or lead. Issues with platelet development result in some mix of low red platelets, low platelets, and low white platelets. A few sorts have an expansion in youthful platelets, called impacts, in the bone marrow or blood. Medicines may incorporate steady care, sedate treatment, and foundational microorganism transplantation.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

ESMO Sarcoma and GIST Symposium 2018 February 5-7, 2018 | Milan, Italy; Genitourinary Cancers Symposium February 8-10, 2018 | California, USA; 4th Annual on Gynecologic Oncology Conference July 18-19, 2018 | Atlanta, USA; ASH Meeting on Hematologic Malignancies September 7-8, 2018 | Chicago, IL; ASH Meeting on Lymphoma Biology August 2-5, 2018 | Washington, DC; ASH Summit on Emerging Immunotherapies for Hematologic Diseases July 12-13, 2018 | Washington, DC; Aga Khan University Joint Session - Surgical Oncology - Evidence & Practice February 2-3, 2018 | Karachi, Pakistan

Hematology Societies in Asia-Pacific

Asia Pacific Hematology Consortium, Asia-Pacific; Asian and Pacific Federation of Organizations for Cancer Research and Control, Asia-Pacific; Asian Cancer Foundation, Asia-Pacific; Asian Clinical Oncology Society: ACOS, Asia-Pacific; Asian Fund for Cancer Research, Asia-Pacific; Asian Hematology Association, Asia-Pacific; Asian Society of Gynecologic Oncology , Asia-Pacific; Australasian Lung Cancer Trials Group, Asia-Pacific ; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific ; Cancer Therapeutics Research Group, Asia-Pacific; Japanese Society of Hematology, Asia-Pacific ; Pan Arab Hematology Association, Asia-Pacific; The Thai Society of Hematology, Asia-Pacific

Track-24

Surgical Oncology

Surgical oncology goes under the field of surgery connected to oncology, which includes the surgical administration of tumors, for the most part harmful tumors. The objectives of the surgical oncologist are to expel the harmful cells and keeping a range of solid tissue encompassing it, otherwise called an unmistakable edge or clear extraction, with a specific end goal to keep the malignancy from that repeating around there. Now and again it is hard to evacuate the entire tumor, so in this way a debulking surgery should be possible to expel however much as tumor as could reasonably be expected and to calm side effects, for example, torment, aviation route obstacle, or dying. Surgical oncologist are additionally called as general surgical oncologist, thoracic surgical oncologists, subspecialty of general surgery, gynecologic oncologists experienced in treating the malignancy patients.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

Hematology Global Summit 2018 September 20-21, 2018 | Bali, Indonesia; Surgical Oncology- Evidence & Practice February 2-3 2018 | Karachi, Pakistan; World Hematology Conference and Medical Oncology Conference May 28-30, 2018 | Osaka, Japan; ESMO Africa Cancer Conference February 14-16, 2018 | Cape Town, South Africa; Global Oncology Conference & Cancer Conference March 14-16, 2018 | Singapore; 4th World cancer Conference and Cancer Prevention Methods Conference April 19-21, 2018 | Valencia, Spain; Global Oncology Conference and Radiology Conference April 16-17, 2018 Dubai, UAE

Track-25

Cancer Therapy

There are more than 200 sorts of malignancy, including skin disease, Breast tumor, colon growth, colon malignancy, lung malignancy, Prostate growth and lymphoma. Side effects and Treatment fluctuates relying upon the kind of Cancer which is at first influenced. A few people with growth will have just a single treatment. Be that as it may, a great many people have a blend of medications, for example, radiation treatment or surgery with chemotherapy. The Anticancer treatments incorporate Chemotherapy, Surgical treatment, Neoadjuvant treatment, Adjuvant treatment, Palliative treatment, Radiotherapy, Immunotherapy, Nutritional treatment, Hormonal treatment, Phototherapy. Phototherapy/proton shaft treatment is the most exceptional among all the malignancy treatments.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

12th World Hematology Conference March 15-16, 2018 | London, UK; 25th Biennial European Association for Cancer Research Conference June 30-July3 2018 Amsterdam; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany; 28th Euro Cancer Science Conference and Cancer Therapy Conference August 09-10, 2018 | Madrid, Spain; 11th European Breast Cancer Conference Mar 21- 23, 2018 | Barcelona, Spain

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; British Society for Haematology, Europe; Egyptian Society of Hematology and Research;  ESMO: European Society for Medical Oncology, Europe; European Academy of Cancer Sciences, Europe; European Association for Cancer Research, Europe; European Cancer Organization: ECCO, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe; European School of Oncology, Europe; European Society for Pediatric Oncology – SIOPE, Europe; European Society of Skin Cancer Prevention, Europe: European Society of Surgical Oncology, Europe;  Federation of European Cancer Societies, Europe; International Society of Pediatric Oncology, Europe;  Organization of European Cancer Institute, Europe

Track-26

Robotic Oncology

Tumor is a gathering of sicknesses in which cells experience unusual development and gap wildly notwithstanding attacking different parts of the body. There are two sorts of diseases, favorable and harmful. Most basic kind of malignancy's incorporate bosom disease, prostate tumor, basal cell and melanoma, colon growth, lung disease, Leukemia and lymphoma. Diseases in guys incorporate lung tumor, prostate malignancy, stomach growth and colorectal tumor. Tumors in females are bosom malignancy, cervical growth lung disease and colorectal disease.

Keeping in mind the end goal to play out the surgery of tumor with more accuracy and agreeable to the patient automated surgeries are favored. Automated surgeries are favored for their better exactness limit, making less number of entry points and quick mending

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

ESMO Sarcoma and GIST Symposium 2018 February 5-7, 2018 | Milan, Italy; Genitourinary Cancers Symposium February 8-10, 2018 | California, USA; 4th Annual on Gynecologic Oncology Conference July 18-19, 2018 | Atlanta, USA; ASH Meeting on Hematologic Malignancies September 7-8, 2018 | Chicago, IL; ASH Meeting on Lymphoma Biology August 2-5, 2018 | Washington, DC; ASH Summit on Emerging Immunotherapies for Hematologic Diseases July 12-13, 2018 | Washington, DC; Aga Khan University Joint Session - Surgical Oncology - Evidence & Practice February 2-3, 2018 | Karachi, Pakistan

Hematology Societies in USA

American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Head and Neck Society, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Canadian Hematology Society, USA; Childhood Brain Tumor Foundation, USA; Children's Tumor Foundation, USA; Colon Cancer Alliance, USA; Foundation for Women's Cancer, USA; International Society for Laboratory Hematology, USA; International Society of Hematology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; Lung Cancer Foundation of America, USA; Lymphoma Research Foundation, USA; Mexican Society of Hematology, USA; Michigan Society of Hematology and Oncology, USA

Track-27

Hematology and Alternative Medicine

Ayurvedic prescription is an old Indian arrangement of drug which started around 5,000 years back. It isn't only one treatment. It is a method for diagnosing disease and utilizing an extensive variety of medications and strategies. Home grown medication utilizes plants, or a blend of plant extricates, to treat disease and advance wellbeing. It plans to reestablish your body's capacity to ensure, control and mend itself. It is an entire body approach, so takes a gander at your physical, mental and passionate prosperity. It is at times called phytomedicine, phytotherapy or herbal medication. Naturopathic specialists trust that growth emerges from an awkwardness that causes a foundational breakdown inside the body. Homeopathy depends on the hypothesis of treating like with like. So to treat an ailment a homeopathic specialist utilizes minor dosages of a substance that in expansive measurements would really cause the side effects of the ailment.

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

Related Conferences:

12th World Hematology Conference March 15-16, 2018 | London, UK; 25th Biennial European Association for Cancer Research Conference June 30-July3 2018 Amsterdam; 27th International Oncology research Conference and Cancer Stem Cells Conference May 10-12, 2018 | Frankfurt, Germany; 28th Euro Cancer Science Conference and Cancer Therapy Conference August 09-10, 2018 | Madrid, Spain; 11th European Breast Cancer Conference Mar 21- 23, 2018 | Barcelona, Spain

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; British Society for Haematology, Europe; Egyptian Society of Hematology and Research;  ESMO: European Society for Medical Oncology, Europe; European Academy of Cancer Sciences, Europe; European Association for Cancer Research, Europe; European Cancer Organization: ECCO, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe; European School of Oncology, Europe; European Society for Pediatric Oncology – SIOPE, Europe; European Society of Skin Cancer Prevention, Europe: European Society of Surgical Oncology, Europe;  Federation of European Cancer Societies, Europe; International Society of Pediatric Oncology, Europe;  Organization of European Cancer Institute, Europe

Market Analysis

Hematology is a branch of science that incorporates different research regions, for example, pathology, inner pharmaceutical, clinical lab, physiology, immunology and pediatrics. This gathering will witness an accumulation of different fields in Hematology and as it includes an immense scope of restorative streams inside it. This meeting will be an incredible stage for interdisciplinary associations, to trade and offer learning under a solitary rooftop.

The sorting out advisory group is preparing for an energizing and useful gathering program including whole addresses, symposia, workshops on an assortment of themes, blurb introductions and different projects for members from everywhere throughout the world. We welcome you to go along with us at the Hematologic Oncology 2018, where you will make certain to have an important involvement with researchers from around the Globe.

Importance & Scope:

Hematologic Oncology 2018 will be the best stage for every one of the hematologists, oncologists, examine researchers, understudies who are working in this field to trade their insight identified with Hematologic Oncology and treatment. This universal occasion is a push to comprehend the fundamental organic methods which are corrected to expand viability, accuracy, survivability, and personal satisfaction.

Specialists will clarify how another age of treatment alternatives gives patients new expectation in the battle against Leukemia and Hematologic Oncology.

Topographically, the worldwide Leukemia and Hematologic Oncology treatment advertise is grouped into locales in particular, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa .North America takes the biggest offer of worldwide Hematologic Oncology treatment showcase took after by Europe. The worldwide Leukemia and Hematologic Oncology treatment market is expected to grow in future due to increasing investment by multinational companies in cancer research.

Why Paris?

Paris, the cosmopolitan capital of France, is one of the largest groups in Europe and the city is a symbol of French culture, with 2.2 million people living in the dense, central city and almost 12 million people living in the whole metropolitan area. Located in the north of France on the river Seine, Paris has the well-deserved status of being the most beautiful and romantic of all cities. It has an annual 30 million foreign visitors, and so is one of the most visited cities in the world. Paris needs no introduction. It’s synonymous with food, culture, fashion, and architecture, rarely unsatisfactory to those who visit. Despite being the dream destination for millions of people each year, the French capital still has plenty hidden secrets to offer beyond the Eiffel Tower and its world-class museums. For centuries, Paris has attracted artists from around the world, who arrive in the city to educate themselves and to seek inspiration from its vast pool of artistic resources and galleries. As a result, Paris has acquired a reputation as the “City of Art”. Paris is the home of imperative museums and cultural institutions and to truly understand Paris you have to immerse yourself in the city’s artistic culture. Beyond the Louvre and the Musée d’Orsay, you can get your culture fix at the modernized Picasso Museum and the new Foundation Louis Vuitton, not to mention dozens of small museums and galleries. Paris has more than 421 municipal parks and gardens. The city is also a major rail, highway, and air-transport center, served by the two international airports Paris-Charles de Gaulle and Paris-Orly. Paris has many nicknames, but its most famous is “La Ville-Lumière” (“The City of Light”), a name it owes first

Conference Highlights:

  • Leukemia
  • Hematology
  • Hematologic Oncology
  • Blood Disorders and Blood Oncology
  • Leukemia Immunology
  • Leukemia Drugs
  • Anemia & Bleeding Disorders
  • Haematologic Malignancies
  • Lymphoma
  • Myeloma
  • Hematologic Malignancies: Prognosis
  • Immunohematology
  • Biomarkers in Hematology
  • Hematopathology
  • Bone Marrow Transplantation and Surgery
  • Pediatric Hematology
  • Advance in Bone Marrow Transplantation
  • Hematology Nursing
  • Stem Cell Research
  • Hematology Market
  • Case reports and Epidemiology
  • Platelets
  • Robotic Oncology
  • Myelodysplastic syndromes
  • Surgical Oncology
  • Hematology and Alternative Medicine
  • Cancer Therapy

World Hematology Societies

Hematology societies in Europe

Association of European Cancer Leagues

British Society for Haematology

Egyptian Society of Hematology and Research

ESMO: European Society for Medical Oncology

European Academy of Cancer Sciences

European Association for Cancer Research

European Cancer Organisation: ECCO

European Organization for Research and Treatment of Cancer

European Prostate Cancer Coalition

European School of Oncology

European Society for Pediatric Oncology - SIOPE

European Society of Skin Cancer Prevention

European Society of Surgical Oncology

Federation of European Cancer Societies

International Society of Pediatric Oncology

Organization of European Cancer Institute

Turkish Society of Hematology

Turkish Society of Pediatric Hematology

Hematology Societies in USA

American Brain Tumor Association

American Cancer Society

American Childhood Cancer Organization

American Head and Neck Society

American Society for Radiation Oncology

American Society of Clinical Oncology

Association of Community Cancer Centers

Canadian Hematology Society

Childhood Brain Tumor Foundation

Children's Tumor Foundation

Colon Cancer Alliance

Foundation for Women's Cancer

International Society for Laboratory Hematology

International Society of Hematology

International Society on Thrombosis and Haemostasis, Inc

Lung Cancer Foundation of America

Lymphoma Research Foundation

Mexican Society of Hematology

Michigan Society of Hematology and Oncology

Michigan Society-Hematology

National Brain Tumor Society

Society of Hematologic Oncology

The American Society of Hematology

Hematology societies in Asia Pacific

Asia Pacific Hematology Consortium

Asian and Pacific Federation of Organizations for Cancer Research and Control

Asian Cancer Foundation

Asian Clinical Oncology Society: ACOS

Asian Fund for Cancer Research

Asian Hematology Association

Asian Pacific Journal of Cancer Prevention

Asian Society for Neuro-Oncology

Asian Society of Gynecologic Oncology

Australasian Lung Cancer Trials Group

Black Sea Countries Coalition on Breast and Cervical Cancer Prevention

Cancer Therapeutics Research Group

Japanese Society of Hematology

Pan Arab Hematology Association

The Thai Society of Hematology

Hematology societies in Africa

Africa Cancer Foundation

African Cancer Registry Network

African Journal of Cancer | Mediterranean Oncology Society

African Organization for Research and Training in Cancer

African Women’s Cancer Awareness Association

Afrox - Improving Cancer Care in Africa

CHOC Childhood Cancer Foundation South Africa

Haematology and Oncology Society of Africa

Morocco - World Health Organization

Oncology for Africa ONLUS - Afron

South African Clinical Haematology Society

South African Society of Haematology

World Health Organisation - Africa Region

Hematology Hospitals in World

Hematology Hospitals in Europe

Aarhus Universitetshospital, Nørrebrogade

Agaplesion Bethanien Hospital Heidelberg

Allgemeines Krankenhaus der Barmherzigen Brüder

American Hospital of Paris

ATOS-Praxisklinik Heidelberg

Axis Specialty Hospital

Bristol Haematology and Oncology Centre

Capio Sankt Görans Hospital

Centre Hospitalier de Versailles, France

Centrum Medyczne LUXMED

Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie

Charité - Universitätsmedizin Berlin

Chuv University Hospital Vaudois

Chuv University Hospital Vaudois

Clinica Sant'Anna

Clinical Hospital Dubrava

Clinique Bois-Cerf

Clinique La Colline

Cyberknife Center Hamburg

Evang. Krankenhaus Salem

Great Ormond Street Hospital

Gustave Roussy

Hematology-transfusion department

Hôpital Saint-Antoine

Hôpital Saint-Antoine, france

Hospital Erasme

Hospital group Paris Saint-Joseph

Hospital Ruber Internacional

Ics-partners Recruitment & Training

Institute of Hematology and Blood Transfusion (ÚHKT)

IRCCS Ospedale San Raffaele

Karolinska University Hospital

Karolinska University Hospital

King's College Hospital NHS Foundation Trust

Klinik Sankt Elisabeth

Klinikum Stuttgart - Standortmitte

Krankenhaus der Elisabethinen Graz

Landeskrankenhaus Graz South West, West Location

Laurent Quint

London Bridge Hospital

Manchester Royal Infirmary

Na Homolce Hospital

National Center for Tumor Diseases - NCT

Odense Universitetshospital

Rigshospitalet

Rudolfinerhaus private clinic GmbH

Sahlgrenska University Hospital

Saint-Louis Hospital

Samodzielny Publiczny Centralny Szpital Kliniczny

Sint-Augustinus

Skånes University Hospital

St. Josef Hospital Heidelberg GmbH

Swedish Cancer Institute - Seattle

Szpital Czerniakowski

Szpital Specjalistyczny im. Świętej Rodziny

The Christie NHS Foundation Trust

UCLH Macmillan Cancer Centre

UKD - Klinik für Hämatologie, Onkologie und Klinische Immunologie

Unicare Medical Center Ltd.

Università Vita - Salute San Raffaele

Universitätsklinikum Heidelberg

Universitätsklinikum Heidelberg Thorax Clinic Heidelberg

Universitätsspital Basel

University Hospital Antwerp

University Hospital Motol

University Hospital of Geneva

University Hospital of Zürich

University Hospital RWTH Aachen

University Medical Center Hamburg-Eppendorf (UKE)

Wiener Privatklinik

Hematology Hospitals in USA

Alabama Oncology: Bondly Cara C MD

Atlanta Hematology & Oncology: Allen Robert S MD

Berkshire Hematology Oncology

Birmingham Hematology Oncology

Boston Children's Hospital: Hematology/Oncology

California Hematology Oncology Medical Group

Cancer Center | Massachusetts General Hospital

Cancer Center at Boston Medical Center

Cancer hospital and patient support US offices of Oasis of Hope Hospital

Cancer Institute of Florida

Cancer Treatment Centers of America at Eastern Regional Medical Center

Cancer Treatment Centers of America at Midwestern Regional Medical Center

Cancer Treatment Centers of America at Southeastern Regional Medical Center

Cancer Treatment Centers of America at Western Regional Medical Center

Children's Hospital Los Angeles: Hematology and Oncology

Children's Hospital: Pediatric Hematology Oncology

Children's of Alabama - Pediatric Cancer and Blood Disorders

Children's Specialty Center - Hematology/Oncology Clinic

Chilton Memorial Hospital: Frank Martin J MD

Comprehensive Cancer Center

Cook Children's Hematology & Oncology Clinic

Cook Children's Hematology and Oncology Clinic

Dana-Farber Cancer Institute

East Texas Hematology/oncology

Floating Hospital for Children - Pediatric Hematology/Oncology

Florida Medical Clinic Hematology & Oncology Land O'Lakes Multi Specialty Campus

Florida Medical Clinic Hematology and Oncology

Gainesville Hematology Oncology Associates

Hematology & Oncology Associates of Alabama - HOAA

Hematology Oncology & Infusion Therapy Center: Mountain View Center

Hematology/Oncology Clinic at Harborview

HOAA Gadsden - Hematology & Oncology Associates of Alabama

Houston Methodist Academic Medicine Associates - Hematology

Huntsman Cancer Institute - University of Utah Health Care

Kadlec Hematology and Oncology Clinic - Kennewick

Loma Linda University Pediatrics Hematology-Oncology

Lucile Packard Children’s Hospital: Hematology

Marin Cancer Care - Hematology & Oncology Clinic

Massachusetts General Hospital

Mayo Clinic Hematology

MD Anderson Cancer Center

Med Star Georgetown University Hospital:Hematology/Oncology

Memorial Sloan Kettering Brooklyn Infusion Center

Mercer Bucks Hematology Oncology

Mid Florida Cancer Centers

Mid Florida Hematology

Minnesota Oncology - Chaska Clinic

Minnesota Oncology Hematology

Northwest Florida Hematology Oncology Tommy Hamm Sr Cancer Center

Oncology and Hematology Specialists - Morristown Medical Center

Oncology/Hematology California Pacific Medical Center Pacific Campus

Palo Alto Medical Foundation,Commercial Crossing Office

Parkland Hematology & oncology Clinic

Pediatric Hematology-Oncology | Mass General Hospital for Children

Premier Hematology & Oncology - Celebration

Premier Hematology & Oncology - Kissimmee

Providence Pediatric Hematology Oncology Clinic

Regional Cancer Center at Ipmc St

Roswell Park Cancer Institute

SE Florida Hematology-Oncology

Seton Family of Doctors at Hays Hematology/Oncology Clinic

Shands Hospital - Hematology and Oncology

South Florida Oncology Hematlgy

South Texas Oncology Group

Southeast Georgia Hematology

Southeast Georgia Physician Associates - Hematology & Oncology

St. Elizabeth Hospital Cancer Center

St. Joseph's Children's Hospital Pediatric Hematology and Oncology

Stanford Hematology Program

Tennova Hematology Oncology

Texas Children's Cancer Center

Texas Hematology Oncology Center

The American Society of Hematology

The Center for Hematology and Oncology

The Johns Hopkins Hospital -Hematology and Oncology

UAB Oncology/Hematology

UCLA Westwood Hematology-Oncology Community Practice Group

UCLA Westwood Oncology Hematology Clinic

UCSF Hematology and Blood and Marrow Transplant

UF Health Hematology - Medical Specialties - Medical Plaza

UF Health Hematology and Medical Oncology - Jacksonville

UNC Lineberger Comprehensive Cancer Center

University Hospital Hematology & Medical Oncology Clinic

University Hospitals Seidman Cancer Center

USA Children's & Women's Hospital

USA Mitchell Cancer Institute

USA Mitchell Cancer Institute - Monroeville

USA Mitchell Cancer Institute Kilborn Clinic

USA Physicians Pediatric Hematology Oncology

UT Physicians Adult Hematology-TMC

Va Hospital Hematology Oncology

Vanderbilt Hematology Clinic

Vannie Cook Children's Clinic

Washington Hospital Center: Shenoy Aarthi G MD

Wellmont Medical Associates Oncology & Hematology Bristo

Winchester Hospital Oncology and Hematology

Winship Cancer Institute of Emory University

Hematology Hospitals in Asia- Pacific

Asian Hospital and Medical Center

Asian Institute of Gastroenterology

Asian Institute of Medical Sciences

Blood Specialist Clinic, Singapore

California Pacific Medical Center: Davies Campus

Cancer Services: California Pacific Medical Center Pacific Campus

Central India Institute of Haematology & Oncology

Chong Hua Hospital Internal Medicine Department - Hematology-Oncology, Yap, Matthew M.D

Columbia Asia Hospital - Ahmedabad

Columbia Asia Hospital - Doddabalapur

Columbia Asia Hospital – Ghaziabad

Columbia Asia Hospital - Hebbal

Columbia Asia Hospital - Mysore

Columbia Asia Hospital - Palam Vihar

Columbia Asia Hospital - Patiala

Columbia Asia Hospital - Salt Lake

Columbia Asia Hospital Pune

Columbia Asia Hospital- Whitefield

Columbia Asia Referral Hospital - Yeshwanthpur

Comprehensive Thalassemia Care, Pediatric Hematology-Oncology & BMT Centre

Credihealth Pvt. Ltd

Guruprasad Hematology Clinic

Haematology Centre, Singapoor

Hawaii Pacific Health

Liver Disease Management & Transplant: Sutter Pacific Medical Foundation

Oncology/Hematology California Pacific Medical Center Pacific Campus

Pacific Alliance Medical Center

Pacific Hematology

Pacific Medical Center - First Hill

Pacific Medical Center - Renton

Pediatric Hematology/Oncology: Sutter Pacific Medical Foundation: San Mateo

Providence Regional Medical Center Everett Pacific Campus

Samaritan Pacific Communities Hospital

Seattle Children's Everett

Sutter East Bay Medical Foundation- Oncology and Hematology

Tahoe Pacific Hospital

Tahoe Pacific Hospital - North

VA Pacific Islands Healthcare System

Yashoda Hematology Clinic

Hematology Hospitals in Africa

AAR Hospital

Aga Khan Hospital

Aga Khan Hospital - Mwanza

Aminu Kano Teaching Hospital

Bagamoyo Hospital

Bugando Hospital - Mwanza

Capital Haematology Hospital

Centro de Saúde de Ponta d'Água

CHU Isaad Hassani de Beni Messous

Dar es Salaam Region

Dermatologie Docteur A. MEKID

Durban Capital Haematology and Surgical Hospital

Durban Haematology Hospital

First Consultant Hospital

Genesis Specialist Hospital

Hopelands Cancer Centre Durban

Hopital Birtraria

Hôpital De Tixeraine

Hôpital El Kettar

Hopital Mustapha Bacha

Hospital Bachir Mentouri

Hospital Lamine Debaghine (eg Jersey)

Kisarawe Hospital

Lagoon Hospital

Lagoon Hospitals Apapa

Lagos University Teaching Hospital

Mkoani Hospital

Muhimbili Hospital

Nafisa Hamoudi Hospital

National Center of Sports Medicine (New NMSC)

National Hospital

Primus International Super Specialty Hospital

Reddington Hospital

Sekou Toure Hospital - Mwanza

The Oncology Centre, South Africa

Tumbi Special Hospital

Vedic Lifecare Hospital

Hematology Institutes in World

Hematology Institutes in Europe

Alma Mater Studiorum Università Di Bologna

Anadolu Medical Center

Heidelberg University

Keele University

Kingston University

Manchester Metropolitan University

Medipol Mega University

Middlesex University

Nottingham Trent University

University of Buckingham

University of Cambridge

University of Chester

University of Leeds

University of Liverpool

University of Nottingham

University of Westminster

University of Wolverhampton

Hematology Institutes in USA

American College of Nursing, Concord

Baylor College of Medicine

Bossier Parish Community College, Bossier City

Central New Mexico Community College

George Washington University, Washington DC

Hudson Hematology Oncology  

Linn-Benton Community College

Mississippi Delta Community College

New Jersey Medical School

Robert Wood Johnson Medical School

Rutgers New Jersey Medical School

St. Catherine University

Stratford University, Falls Church

Texas Children's Cancer Center

The University of Texas Health Science at San Antonio

University of California

University of Pittsburgh

University of Texas Southwestern Medical Center

University of Washington

Yale School of Medicine

Hematology Institutes in Asia Pacific

Christian Medical College and Hospital

Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences

Institute of Medical Education and Research

National university cancer institute

National University Hospital

Peking Union Medical College

Peking University Institute of Hematology

Soochow University, Jiangsu Institute of Hematology Nanjing Medical University

The Chinese University of Hong Kong

Tianjin Medical University

Universiti Putra Malaysia

Universiti Sains Malaysia

Universiti Teknologi Mara

University of Malaya

University of Tokyo

Hematology Institutes in Africa

Mangosuthu University of Technology

Nelson Mandela University

Rhodes University

Stellenbosch University

University of Cape Town

University of Free State

University of KwaZulu

University of KwaZulu-Natal

University of Limpopo

University of Malawi College of Medicine

University of Nairobi

University of Nigeria Nsukka

University of Pretoria

University of South Africa

University of the Western Cape

University of the Witwatersrand

Wits University

Market Analysis report

As indicated by the market of hematological malignancies is communicated to demonstrate consistent development rate amid the conjecture time frame from 2014-2020. This development is driven by central point, for example, rising predominance of different sicknesses and broad R&D rehearses are continuous over the globe to bring new and more compelling medications and details in the market.

Development in innovation, customized prescription, financially savvy treatment methodology is couple of different components anticipated to keep up the development of worldwide blood disease treatment showcase. Be that as it may, unique nature of blood diseases and expanding stringency in the administrative necessities are a portion of the real limitations constraining the development of worldwide blood tumor treatment advertise.

The worldwide market for Hematological disease drugs was evaluated to be $18.7 billion of every 2012. By 2017, the market is relied upon to reach $28.8 billion, developing at a CAGR of 9% in the vicinity of 2012 and 2017.The aggregate worldwide market for hematological confusion medications and diagnostics in 2012 was evaluated at about $72.9 billion. By 2018, the market is relied upon to reach $99.1 billion, developing at a compound yearly development rate (CAGR) of 6.4% in the vicinity of 2012 and 2018. The worldwide blood issue advertises fragment is evaluated at $49.3 billion of every 2012 and is required to reach almost $64.7 billion by 2018. The significant purpose behind the low development rate is the normal decrease in the yearly cost of treating blood issue and the patent lapses of Lovenox, Plavix, Procrit/Epogen, Aranesp, and Neulasta. In 2010, every one of these medications together achieved income of $32 billion into the worldwide blood issue advertise.

To Collaborate Scientific Professionals around the World

Conference Date June 20-21, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Blood Disorders & Transfusion Journal of Blood & Lymph Journal of Hematology & Thromboembolic diseases

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by